503040-01-5

Basic information

• Product Name: Benzoic acid, 4-[[(5-methoxy-1H-benzimidazol-2-yl)thio]methyl]-, methyl ester, monohydrobromide
• CAS NO: 503040-01-5
• Molecular Formula: C17H16N2O3S.BrH
• Molecular Weight: 409.304
• Mol File: 503040-01-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 4-[[(5-methoxy-1H-benzimidazol-2-yl)thio]methyl]-, methyl ester, monohydrobromide(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-[[(5-methoxy-1H-benzimidazol-2-yl)thio]methyl]-, methyl ester, monohydrobromide(503040-01-5)
• EPA Substance Registry System: Benzoic acid, 4-[[(5-methoxy-1H-benzimidazol-2-yl)thio]methyl]-, methyl ester, monohydrobromide(503040-01-5)

Safety Data

• Hazardous Substances Data: 503040-01-5(Hazardous Substances Data)

Upstream product

• 2417-72-3 Methyl 4-(bromomethyl)benzoate 
• 37052-78-1 2-Mercapto-5-methoxybenzimidazole 
• 65-85-0 benzoic acid 

Relevant articles and documents

Inhibitors of histone deacetylase

The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

Inhibitors of histone deacetylase

The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.